Killer bacteria and viruses in urology
Thematic Session 16
-
Location:Room London, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session Infections have ever since accompanied mankind. It is only 80 years since infections have become successfully treatable diseases, by the development of effective anti-infective strategies.
In antibacterial treatment this success is going to be lost, by the increasing threat of antimicrobial resistance. This thematic session will focus on the current problems and evidence in treating infectious diseases in urology.
Institutes: 1Justus-Liebig-Universität, Institut Für Medizinische Mikrobiologie, Giessen, Germany, 2Justus-Liebig-Universität, Klinik Für Urologie, Kinderurologie Und Andrologie, Giessen, Germany, 3Justus-Liebig-Universität, Dept. of Bioinformatics and Systems Biology, Giessen, Germany
Institutes: 1Bnai-Zion Medical Center, Dept. of Urology, Haifa, Israel, 2Technion Israeli Institute of Technology, Dept. of Biotechnology and Food Engineering, Haifa, Israel